AI-based detection of MRI-invisible prostate cancer with nnU-Net.
Source check: Source checked. Not independent scientific confirmation.
Finding: Primary full text reports nnU-Net analysis of 1,475 mpMRI images for MRI-invisible prostate cancer, with five-fold CV. The high false-negative rate is a material limitation.
Technology: nnU-Net adaptive image-recognition system applied to mpMRI; five-fold cross-validation.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- nnU-Net adaptive image-recognition system applied to mpMRI; five-fold cross-validation.
- Test and result
- Internal CV only; no clinical benefit established; preserve the false-negative limitation.
- Limitation / still unknown
- The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.32604/cju.2025.068853
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.